Company · CIK 0001429260 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Fortress Biotech, Inc. · FBIO
Insider activity reported against this company. All insider holders · Files at: ATXI, MBIO, CKPT, NHLD, OACQ. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 AForm 4 → | Jun 24, 9:50 pm EDT | David JinChief Financial Officer | 400,000 | — | — | 1,651,571 | — | |
| Dec 11, 2018 SForm 4 → | Dec 13, 6:10 pm EST | George AvgerinosSVP, BIOLOGICS OPERATIONS | 97,325 | $1.05 | $102,191 | 255,170 | −27.6% | plan? |
| Nov 23, 2018 SForm 4 → | Nov 30, 5:26 pm EST | Robyn HunterChief Financial Officer | 20,370 | $1.29 | $26,277 | 239,759 | −7.83% | plan? late |
| Jan 1, 2018 AForm 4 → | Nov 30, 5:30 pm EST | Malcolm HoenleinDirector | 50,000 | — | — | 285,000 | — | plan? late |
| Jan 1, 2018 AForm 4 → | Nov 30, 5:29 pm EST | Jimmie HarveyDirector | 100,000 | — | — | 450,000 | — | plan? late |
| Jan 1, 2018 AForm 4 → | Nov 30, 5:28 pm EST | J Jay LobellDirector | 100,000 | — | — | 786,000 | — | plan? late |
| Jan 1, 2018 AForm 4 → | Nov 30, 5:27 pm EST | Eric K RowinskyDirector | 100,000 | — | — | 450,000 | — | plan? late |
| Dec 14, 2017 SForm 4 → | Dec 18, 6:46 pm EST | George AvgerinosSVP, BIOLOGICS OPERATIONS | 12,000 | $3.55 | $42,600 | 352,495 | −3.29% | plan? |
| Dec 12, 2017 SForm 4 → | Dec 14, 8:18 pm EST | George AvgerinosSVP, BIOLOGICS OPERATIONS | 44,593 | $3.58 | $159,709 | 364,495 | −10.9% | plan? |
| Nov 29, 2017 AForm 4 → | Dec 14, 8:18 pm EST | George AvgerinosSVP, BIOLOGICS OPERATIONS | 150,000 | — | — | 409,088 | — | plan? late |
| Nov 6, 2017 PForm 4 → | Nov 8, 6:02 pm EST | Lindsay A Rosenwald M.D.PRESIDENT, CEO, Director, 10% Owner | 40,000 | $25.00 | $1,000,000 | 40,000 | — | plan? |
| Jul 14, 2017 DForm 4 → | Jul 21, 4:13 pm EDT | Dov KleinDirector | 13,333 | — | — | 201,668 | — | plan? late |
| Jan 1, 2017 AForm 4 → | Jan 27, 4:22 pm EST | Michael S WeissExec. VC - Strategic Dev., Director, 10% Owner | 552,698 | — | — | 8,001,170 | — | plan? late |
| Jan 1, 2017 AForm 4 → | Jan 27, 4:12 pm EST | Lindsay A Rosenwald M.D.President and CEO, Director, 10% Owner | 552,698 | — | — | 5,857,168 | — | plan? late |
| Jan 1, 2017 AForm 4 → | Jan 24, 7:02 pm EST | Eric K RowinskyDirector | 100,000 | — | — | 350,000 | — | plan? late |
| Jan 1, 2017 AForm 4 → | Jan 24, 7:01 pm EST | J Jay LobellDirector | 100,000 | — | — | 686,000 | — | plan? late |
| Jan 1, 2017 ADForm 4 → | Jan 24, 6:58 pm EST | Dov KleinDirector | 126,666 | — | — | 215,001 | — | plan? late |
| Dec 1, 2016 PForm 4 → | Jan 27, 2017, 4:12 pm EST | Lindsay A Rosenwald M.D.President and CEO, Director, 10% Owner | 731 | $2.03 | $1,484 | 5,304,470 | +0.01% | plan? late |
| Sep 15, 2016 SForm 4 → | Sep 19, 4:23 pm EDT | George AvgerinosSVP, Biologics Operations | 48,912 | $2.55 | $124,576 | 259,088 | −15.9% | plan? |
| Sep 14, 2016 AForm 4 → | Sep 16, 4:08 pm EDT | George AvgerinosSVP, Biologics Operations | 150,000 | — | — | 308,000 | — | plan? |
| Jul 15, 2016 DForm 4 → | Jul 19, 5:23 pm EDT | Dov KleinDirector | 13,333 | — | — | 141,667 | — | plan? |
| Jun 1, 2016 PForm 4 → | Jun 17, 4:01 pm EDT | Lindsay A Rosenwald M.D.President and CEO, Director, 10% Owner | 613 | $2.40 | $1,471 | 5,303,739 | +0.01% | plan? late |
| Jan 1, 2016 AForm 4 → | Jan 5, 5:38 pm EST | Lindsay A Rosenwald M.D.President and CEO, Director, 10% Owner | 510,434 | — | — | 5,303,126 | — | plan? |
| Jan 1, 2016 AForm 4 → | Jan 5, 5:38 pm EST | Michael S WeissExec. VC - Strategic Dev., Director, 10% Owner | 510,434 | — | — | 7,448,472 | — | plan? |
| Jan 1, 2016 AForm 4 → | Jan 5, 4:32 pm EST | J Jay LobellDirector | 100,000 | — | — | 586,000 | — | plan? |
| Jan 1, 2016 AForm 4 → | Jan 5, 4:30 pm EST | Eric K RowinskyDirector | 100,000 | — | — | 250,000 | — | plan? |
| Jan 1, 2016 AForm 4 → | Jan 5, 4:28 pm EST | Dov KleinDirector | 100,000 | — | — | 155,000 | — | plan? |
| Dec 1, 2015 PForm 4 → | Dec 9, 4:54 pm EST | Lindsay A Rosenwald M.D.President and CEO, Director, 10% Owner | 586 | $2.41 | $1,412 | 4,792,692 | +0.01% | plan? late |
| Sep 10, 2015 DForm 4 → | Sep 14, 5:10 pm EDT | George AvgerinosSVP, Biologics Operations | 54,036 | $2.65 | $143,455 | 158,000 | — | plan? |
| Sep 8, 2015 DForm 4 → | Sep 10, 5:19 pm EDT | George AvgerinosSVP, Biologics Operations | 25,804 | $2.60 | $67,042 | 212,036 | — | plan? |
| Sep 4, 2015 DForm 4 → | Sep 8, 5:10 pm EDT | George AvgerinosSVP, Biologics Operations | 2,136 | $2.60 | $5,554 | 237,840 | — | plan? |
| Sep 2, 2015 DForm 4 → | Sep 4, 5:20 pm EDT | George AvgerinosSVP, Biologics Operations | 43,100 | $2.59 | $111,719 | 239,976 | — | plan? |
| Sep 1, 2015 DForm 4 → | Sep 3, 5:47 pm EDT | George AvgerinosSVP, Biologics Operations | 158 | $2.70 | $427 | 283,076 | — | plan? |
| Aug 31, 2015 DForm 4 → | Sep 2, 5:10 pm EDT | George AvgerinosSVP, Biologics Operations | 3,500 | $2.94 | $10,295 | 283,234 | — | plan? |
| Aug 21, 2015 DForm 4 → | Aug 25, 4:26 pm EDT | George AvgerinosSVP, Biologics Operations | 10,000 | $2.55 | $25,458 | 286,734 | — | plan? |
| Aug 19, 2015 DForm 4 → | Aug 21, 1:57 pm EDT | George AvgerinosSVP, Biologics Operations | 11,266 | $3.00 | $33,798 | 296,734 | — | plan? |
| Aug 13, 2015 AForm 4 → | Aug 14, 4:26 pm EDT | George AvgerinosSVP, Biologics Operations | 300,000 | — | — | 308,000 | — | plan? |
| Jul 15, 2015 AForm 4 → | Jul 17, 4:26 pm EDT | Dov KleinDirector | 50,000 | — | — | 55,000 | — | plan? |
| Jun 1, 2015 PForm 4 → | Jun 3, 4:33 pm EDT | Lindsay A Rosenwald M.D.President and CEO, Director, 10% Owner | 785 | $1.80 | $1,413 | 4,792,106 | +0.02% | plan? |
| Mar 12, 2015 AForm 4 → | Mar 16, 4:58 pm EDT | J Jay LobellDirector | 100,000 | — | — | 486,000 | — | plan? |
| Mar 12, 2015 AForm 4 → | Mar 16, 4:53 pm EDT | Eric K RowinskyDirector | 100,000 | — | — | 150,000 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 14, 2017 AForm 4 → | Jul 21, 4:13 pm EDT | Dov KleinDirector | 13,333 | — | — | 53,332 | — | late |
| Mar 10, 2017 AForm 4 → | Jul 21, 4:11 pm EDT | Malcolm HoenleinDirector | 16,666 | — | — | 49,998 | — | late |
| Mar 10, 2017 AForm 4 → | Jul 21, 4:08 pm EDT | Jimmie HarveyDirector | 33,332 | — | — | 49,998 | — | late |
| Jan 1, 2017 AForm 4 → | Jan 24, 6:58 pm EST | Dov KleinDirector | 26,666 | — | — | 39,999 | — | late |
| Jan 1, 2017 AForm 4 → | Jan 24, 6:56 pm EST | Malcolm HoenleinDirector | 16,666 | — | — | 33,332 | — | late |
| Jan 1, 2017 AForm 4 → | Jan 24, 6:54 pm EST | Jimmie HarveyDirector | 33,332 | — | — | 33,332 | — | late |
| Jul 15, 2016 AForm 4 → | Jul 19, 5:23 pm EDT | Dov KleinDirector | 13,333 | — | — | 13,333 | — | |
| Mar 14, 2016 AForm 4 → | Mar 28, 6:20 pm EDT | Jimmie HarveyDirector | 33,332 | — | — | 16,666 | — | late |
| Mar 14, 2016 AForm 4 → | Mar 28, 6:18 pm EDT | Malcolm HoenleinDirector | 16,666 | — | — | 16,666 | — | late |
| Jul 15, 2015 DForm 4 → | Jul 17, 4:35 pm EDT | George AvgerinosSVP, Biologics Operations | 200,000 | $3.53 | $706,000 | 0 | — |
Filed by this entity as an insider elsewhere — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 17, 2017 AForm 4 → | Jun 7, 5:31 pm EDT | Checkpoint Therapeutics, Inc.CKPT | 721,699 | — | — | 2,702,705 | — | plan? late |
| Sep 30, 2016 AForm 4 → | Jun 7, 2017, 5:43 pm EDT | MUSTANG BIO, INC.no symbol | 1,132,653 | — | — | 10,132,653 | — | plan? late |
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.